|
Market Closed -
Toronto S.E.
00:00:00 03/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.470 CAD | -9.26% |
|
-8.12% | +12.21% |
Company Valuation: Cardiol Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 142 | 43.96 | 71.77 | 151 | 130.4 | 171.7 | - | - |
| Change | - | -69.05% | 63.28% | 110.34% | -13.65% | 31.73% | - | - |
| Enterprise Value (EV) 1 | 142 | 43.96 | 36.84 | 120.4 | 108.9 | 152.7 | 165.1 | 171.7 |
| Change | - | -69.05% | -16.19% | 226.78% | -9.5% | 40.14% | 8.16% | 3.99% |
| P/E | -3.19x | -1.41x | -2.5x | -3.63x | -3.36x | -3.06x | -5.01x | -21.5x |
| PBR | - | - | 2.55x | 6.18x | 6.41x | 6.53x | 45.9x | - |
| PEG | - | 0x | 0.2x | -0.2x | 0.1x | -0.1x | 0.1x | 0.3x |
| Capitalization / Revenue | 1,803x | - | - | - | - | - | 103x | 3.26x |
| EV / Revenue | 1,803x | - | - | - | - | - | 99.1x | 3.26x |
| EV / EBITDA | -4.74x | -1.07x | -1.25x | -3x | -3.18x | -4.25x | -8.12x | -8.33x |
| EV / EBIT | -3.67x | -1.06x | -1.24x | -2.99x | -3.17x | -4.18x | -4.52x | -27.3x |
| EV / FCF | -6.03x | - | -1.46x | -4.8x | -4.56x | -4.9x | -5.29x | -2.65x |
| FCF Yield | -16.6% | - | -68.5% | -20.8% | -21.9% | -20.4% | -18.9% | -37.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.73 | -0.49 | -0.44 | -0.51 | -0.39 | -0.4804 | -0.2934 | -0.0685 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.0788 | - | - | - | - | - | 1.667 | 52.75 |
| EBITDA 1 | -29.95 | -41.12 | -29.54 | -40.11 | -34.21 | -35.9 | -20.34 | -20.62 |
| EBIT 1 | -38.66 | -41.34 | -29.79 | -40.28 | -34.32 | -36.49 | -36.54 | -6.288 |
| Net income 1 | -31.64 | -30.93 | -28.13 | -36.68 | -33.82 | -36.11 | -37.94 | -15.29 |
| Net Debt 1 | - | - | -34.93 | -30.58 | -21.42 | -19.05 | -6.594 | - |
| Reference price 2 | 2.330 | 0.690 | 1.100 | 1.850 | 1.310 | 1.470 | 1.470 | 1.470 |
| Nbr of stocks (in thousands) | 60,954 | 63,703 | 65,247 | 81,603 | 99,514 | 116,823 | - | - |
| Announcement Date | 3/23/22 A | 3/28/23 A | 4/1/24 A | 3/31/25 A | 3/31/26 A | - | - | - |
1CAD in Million2CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.06x | - | -4.25x | - | 123M | |
| 16.47x | 6.17x | 11.83x | 1.81% | 62.23B | |
| 29.48x | 7.92x | 26.5x | 0.05% | 54.92B | |
| 37.71x | 6.69x | 19.98x | 0.86% | 55.26B | |
| 33.73x | 3.23x | 13.93x | -.--% | 42.59B | |
| 47.65x | 5.47x | 29.98x | -.--% | 41.08B | |
| -19.53x | 189.01x | -20.8x | -.--% | 40.33B | |
| 44.75x | 7.99x | 26.76x | -.--% | 33.12B | |
| 32.06x | 8.14x | 21.19x | 0.4% | 32.61B | |
| -68.85x | 12.63x | -70.58x | -.--% | 23.98B | |
| Average | 15.04x | 27.47x | 5.45x | 0.35% | 38.62B | |
| Weighted average by Cap. | 21.26x | 25.92x | 10.79x | 0.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CRDL Stock
- Valuation Cardiol Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
